Gene expression analysis has become a cornerstone of modern genomics, enabling researchers and healthcare providers to understand how genes are activated, regulated, and expressed in various biological conditions. From cancer diagnostics and precision medicine to drug discovery and transcriptomics research, the demand for advanced gene expression analysis solutions is rising rapidly worldwide.
The global gene expression analysis market is projected to grow from USD 4.23 billion in 2026 to USD 5.93 billion by 2031, at a CAGR of 7.0% during the forecast period. The market was valued at USD 4.01 billion in 2025. The growth of the gene expression analysis market is driven by the increasing adoption of transcriptomics technologies and the rising demand for precision medicine, targeted therapies, and RNA-based research.
The global gene expression analysis market is witnessing strong growth due to increasing investments in genomics research, expanding applications of RNA sequencing (RNA-Seq), and rising adoption of personalized medicine. Leading biotechnology and life sciences companies are continuously introducing innovative sequencing platforms, PCR systems, bioinformatics software, and transcriptomics solutions to strengthen their market presence.
Below are the top 10 leading companies shaping the future of the gene expression analysis market.
1. Thermo Fisher Scientific
Thermo Fisher Scientific is widely recognized as one of the dominant players in gene expression analysis. The company offers a broad portfolio of qPCR systems, RNA sequencing tools, microarrays, reagents, and bioinformatics solutions. Its Applied Biosystems and Invitrogen product lines are extensively used in academic research and clinical laboratories.
Key products include:
- QuantStudio Real-Time PCR Systems
- TaqMan Gene Expression Assays
- Ion Torrent sequencing platforms
The company’s strong global distribution network and continuous investments in genomics innovation have strengthened its leadership position in transcriptomics and molecular diagnostics.
2. Illumina
Illumina is a global leader in next-generation sequencing (NGS) technologies and plays a crucial role in gene expression analysis. The company’s sequencing systems support high-throughput RNA sequencing applications for oncology, immunology, and precision medicine research.
Major offerings include:
- NovaSeq Series
- NextSeq Platforms
- TruSeq RNA library preparation kits
Illumina’s sequencing technologies are extensively adopted for transcriptome profiling and differential gene expression studies across pharmaceutical and research organizations worldwide.
3. QIAGEN
QIAGEN specializes in molecular testing and sample preparation technologies that are critical for gene expression workflows. The company provides integrated solutions covering RNA extraction, PCR assays, sequencing preparation, and bioinformatics analysis.
Key strengths include:
- RNA purification technologies
- GeneReader NGS systems
- Quantitative PCR solutions
QIAGEN’s strong expertise in molecular diagnostics and infectious disease testing has expanded its applications in translational genomics and biomarker discovery.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156613968
4. Agilent Technologies
Agilent Technologies is a major provider of genomic analysis instruments and microarray technologies. The company delivers advanced platforms for gene expression profiling, nucleic acid analysis, and bioinformatics research.
Its portfolio includes:
- SurePrint Microarrays
- TapeStation systems
- RNA quality analysis tools
Agilent’s solutions are widely used in cancer genomics, agricultural biotechnology, and pharmaceutical research laboratories.
5. Bio-Rad Laboratories
Bio-Rad Laboratories is a key player in digital PCR and gene expression quantification technologies. The company has gained strong recognition for its droplet digital PCR (ddPCR) systems that provide highly accurate gene expression measurements.
Important offerings include:
- QX200 Droplet Digital PCR System
- CFX Real-Time PCR Systems
- Single-cell RNA sequencing solutions
Bio-Rad continues to strengthen its position through innovations in single-cell analysis and transcriptomics research.
6. F. Hoffmann-La Roche
Roche is a leading healthcare and diagnostics company with significant expertise in molecular diagnostics and gene expression analysis. The company develops PCR-based diagnostic systems and sequencing technologies for clinical and research applications.
Key technologies include:
- LightCycler PCR Systems
- Sequencing by Expansion (SBX) technology
- Oncology-focused molecular diagnostics
Roche’s strong focus on precision medicine and cancer diagnostics continues to drive innovation in transcriptomics and biomarker analysis.
7. Revvity
Formerly part of PerkinElmer, Revvity has expanded its capabilities in genomics, cellular imaging, and molecular diagnostics. The company offers advanced solutions for RNA analysis, biomarker discovery, and high-throughput screening.
Its strengths include:
- Automation systems
- Transcriptomics workflows
- Multiomics research solutions
Revvity is increasingly focusing on precision medicine and translational research applications.
8. Oxford Nanopore Technologies
Oxford Nanopore Technologies is revolutionizing sequencing with portable nanopore-based platforms that enable real-time RNA and DNA sequencing.
Popular platforms include:
- MinION
- GridION
- PromethION
The company’s direct RNA sequencing technology allows researchers to study full-length transcripts and RNA modifications with high flexibility and scalability.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=156613968
9. 10x Genomics
10x Genomics is a pioneer in single-cell transcriptomics and spatial gene expression analysis. The company’s Chromium and Visium platforms are widely used in advanced genomics research.
Key applications include:
- Single-cell RNA sequencing
- Spatial transcriptomics
- Immune profiling
Its technologies help researchers better understand cellular heterogeneity in cancer, neuroscience, and immunology research.
10. Merck KGaA
Merck KGaA provides a broad range of life science tools, reagents, and molecular biology products used in gene expression analysis workflows.
Its offerings support:
- RNA isolation
- PCR analysis
- Transcriptomics sample preparation
The company’s Sigma-Aldrich portfolio strengthens its global footprint in genomics research and pharmaceutical applications.
Competitive Landscape of the Gene Expression Analysis Market
The gene expression analysis market remains highly competitive, with companies focusing on:
- Next-generation sequencing advancements
- Single-cell transcriptomics
- AI-driven bioinformatics
- Precision medicine applications
- Automation and workflow integration
Strategic collaborations, acquisitions, and product launches continue to reshape the competitive environment. Companies are increasingly investing in RNA sequencing technologies, cloud-based analytics, and spatial genomics platforms to meet growing research and clinical demands.
Future Outlook
The future of gene expression analysis is expected to be driven by:
- Rising adoption of personalized medicine
- Growing cancer genomics research
- Expansion of single-cell sequencing technologies
- Increased use of AI and bioinformatics
- Advancements in spatial transcriptomics
As genomic technologies become more accessible and cost-effective, leading companies are expected to accelerate innovation and expand their presence across clinical diagnostics, drug development, and translational medicine.
Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=156613968